fda changes semaglutide just got FDA-approved for kidney disease. This everything., January 2025. The approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in FDA crackdown on off-brand Ozempic

Under hypoxic conditions, L-2-hydroxyglutarate (L-2-HG) was proven to be generated by lactate dehydrogenase A (LDHA) and malate dehydrogenase (MDH) 88,89

Judicial Panel on Multidistrict Litigation (JPML) seeking to consolidate federal lawsuits related to video game addiction

Most patients tolerate semaglutide well and find that the benefits of successful weight loss outweigh any temporary side effects they may experience

If you notice severe or long-lasting symptoms, reach out to your healthcare provider for advice

As with pregnancy, it remains crucial to consult with a healthcare provider when considering glutathione supplementation during breastfeeding to ensure it aligns with individual health needs